Welcome to the Pfizer Co-Pay Portal

ADCETRIS^® (brentuximab vedotin)
Terms and Conditions:
By using the Pfizer Oncology Together™ Co-Pay Savings Program for Injectables for ADCETRIS, you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions described below:

• Eligible patients with commercial prescription drug insurance coverage for ADCETRIS may pay as little as $0 or per administration. Patient out of pocket expense will vary. The value of this offer is limited to annual benefit of $15,000. Once a patient reaches the annual maximum benefit patient is responsible for paying the remaining monthly out of pocket costs.
• Patients are not eligible for this offer if they are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veteran Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as "La Reforma de Salud").
• Patient must have private insurance. Offer is not valid for cash paying patients.
• This offer is not valid when the entire cost of your prescription drug is eligible to be reimbursed by your private insurance plan or other private health or pharmacy benefit programs.
• You must deduct the value of this offer from any reimbursement request submitted to your private insurance plan, either directly by you or on your behalf.
• You are responsible for reporting use of the Pfizer Oncology Together Co-Pay Savings Program for Injectables for ADCETRIS to any private insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the co-pay card, as may be required. You should not use the co-pay card if your insurer or health plan prohibits use of manufacturer co-pay cards.
• You must be 2 years of age or older to redeem the co-pay card.
• The Pfizer Oncology Together Co-Pay Savings Program for Injectables for ADCETRIS is not valid where prohibited by law.
• The benefit under the Pfizer Oncology Together Co-Pay Savings Program for Injectables for ADCETRIS is offered to, and intended for the sole benefit of, eligible patients and may not be transferred to or utilized for the benefit of third parties, including, without limitation, third party payers, pharmacy benefit managers, or the agents of either.
• Third party payers, pharmacy benefit managers, or the agents of either, are prohibited from assisting patients with enrolling in the Pfizer Oncology Together Co-Pay Savings Program for Injectables for ADCETRIS.
• The Pfizer Oncology Together Co-Pay Savings Program for Injectables for ADCETRIS cannot be combined with any other external savings, free trial or similar offer for the specified prescription (including any program offered by a third party payer or pharmacy benefit manager, or an agent of either, that adjusts patient cost- sharing obligations, through arrangements that may be referred to as "accumulator adjustment" or "co-pay maximizer" programs)
• Some health insurers or pharmacy benefit managers (or their agents) may have established accumulator adjustment or co-pay maximizer programs based on the availability of support under the Pfizer Oncology Together Co-Pay Savings Program for Injectables for ADCETRIS and/or exclude the financial assistance provided under the offer co-pay card program from counting towards patient deductibles or out-of-pocket cost limitations.
• Patients subject to an accumulator adjustment or co-pay maximizer program are not eligible for this offer. Since you may be unaware whether you are subject to an accumulator adjustment or co-pay maximizer program when you enroll in this offer, Pfizer may monitor program utilization data and reserves the right to discontinue, reduce, or otherwise modify this offer at any time without notice.
• Co-pay card will be accepted only at participating pharmacies.
• If your pharmacy does not participate, you may be able to submit a request for a rebate in connection with this offer.
• The Pfizer Oncology Together Co-Pay Savings Program for Injectables for ADCETRIS is not health insurance.
• Offer good only in the U.S. and Puerto Rico.
• The Pfizer Oncology Together Co-Pay Savings Program for Injectables for ADCETRIS is limited to 1 per person during this offering period and is not transferable.
• No other purchase is necessary.
• Data related to your redemption of the Pfizer Oncology Together Co-Pay Savings Program for Injectables for ADCETRIS may be collected, analyzed, and shared with Pfizer, for market research and other purposes related to assessing Pfizer's programs. Data shared with Pfizer will be aggregated and de-identified; it will be combined with data related to other co-pay card redemptions and will not identify you.
• Pfizer reserves the right to rescind, revoke or amend this offer without notice.
• Offer expires 12/31/2025.
• For questions regarding the offer, please call 1-877-744-5675, visit https://www.pfizeroncologytogether.com/ or write Pfizer Oncology Together Co-Pay Savings Program for Injectables, 2730 S. Edmonds Lane, Suite 300, Lewisville, TX 75067.

ELELYSO^® (taliglucerase alfa)
Terms and Conditions:
By using this Co-Pay Program, you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions described below:

• Patients are not eligible to use this card if they are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as "La Reforma de Salud").
• Patient must have private insurance. Offer is not valid for cash paying patients. The value of this Co-pay Card is limited to a maximum of $15,000 per calendar year.
• This co-pay card is not valid when the entire cost of your prescription drug is eligible to be reimbursed by your private insurance plan or other private health or pharmacy benefit programs.
• You must deduct the value of this co-pay card from any reimbursement request submitted to your private insurance plan, either directly by you or on your behalf.
• You are responsible for reporting use of the co-pay card to any private insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the co-pay card, as may be required. You should not use the co-pay card if your insurer or health plan prohibits use of manufacturer co-pay cards.
• Patient must be 4 years of age or older for redemption of co-pay card for ELELYSO.
• This co-pay card is not valid for Massachusetts residents whose prescriptions are covered in whole or in part by third party insurance.
• This co-pay card is not valid where prohibited by law.
• Co-pay card cannot be combined with any other savings, free trial or similar offer for the specified prescription.
• Co-pay card will be accepted only at participating pharmacies.
• If your pharmacy does not participate, you may be able to submit a request for a rebate in connection with this offer.
• This co-pay card is not health insurance.
• The co-pay program is available only through the Gaucher Personal Support program. For any questions, please call Gaucher Personal Support at 1-855-ELELYSO (1-855-353-5976).
• Offer good only in the U.S. and Puerto Rico.
• Co-pay card is limited to 1 per person during this offering period and is not transferable.
• No other purchase is necessary.
• No membership fee.
• Data related to your redemption of the co-pay card may be collected, analyzed, and shared with Pfizer, for market research and other purposes related to assessing Pfizer's programs. Data shared with Pfizer will be aggregated and de-identified; it will be combined with data related to other co-pay card redemptions and will not identify you.
• Pfizer reserves the right to rescind, revoke or amend this offer without notice.
• Offer expires 12/31/2025.

For more information, visit our website www.elelyso.com, call 1-855-353-5976, or contact us at 2730 S. Edmonds Lane, Suite 300, Lewisville, TX 75067.

ELREXFIO™ (elranatamab-bcmm)
Terms and Conditions:
By using this Co-Pay Program, you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions described below:

• The Pfizer Oncology Together™ Co-Pay Savings Program for Injectables for ELREXFIO is not valid for patients who are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as "La Reforma de Salud").
• Program offer is not valid for cash-paying patients. With this program, eligible patients may pay as little as $0 co-pay per ELREXFIO treatment, subject to a maximum benefit of $25,000 per calendar year for out-of-pocket expenses for ELREXFIO including co-pays or coinsurances. The amount of any benefit is the difference between your co-pay and $0. After the maximum of $25,000 you will be responsible for the remaining monthly out-of-pocket costs.
• Patient must have private insurance with coverage of ELREXFIO. This offer is not valid when the entire cost of your prescription drug is eligible to be reimbursed by your private insurance plans or other private health or pharmacy benefit programs.
• You must deduct the value of this assistance from any reimbursement request submitted to your private insurance plan, either directly by you or on your behalf.
• You are responsible for reporting use of the program to any private insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the program, as may be required. You should not use the program if your insurer or health plan prohibits use of manufacturer co-pay assistance programs.
• Whether a co-pay expense is eligible for the Pfizer Oncology Together Injectables Co-Pay Program for ELREXFIO benefit will be determined at the time the benefit is paid. Co-pay expenses must be in connection with a separately paid claim for ELREXFIO administered in the outpatient setting.
• Patient must be 18 years of age or older for redemption of co-pay card.
• This program is not valid where prohibited by law.
• The benefit under the program is offered to, and intended for the sole benefit of, eligible patients and may not be transferred to or utilized for the benefit of third parties, including, without limitation, third party payers, pharmacy benefit managers, or the agents of either.
• This program cannot be combined with any other external savings, free trial or similar offer for the specified prescription (including any program offered by a third-party payer or pharmacy benefit manager, or an agent of either, that adjusts patient cost-sharing obligations, through arrangements that may be referred to as "accumulator" or "maximizer" programs).
• Third party payers, pharmacy benefit managers, or the agents of either, are prohibited from assisting patients with enrolling in the program.
• Co-pay card will be accepted only at participating pharmacies.
• This program is not health insurance.
• This program is good only in the U.S. and Puerto Rico.
• This program is limited to 1 per person during this offering period and is not transferable.
• No other purchase is necessary.
• Data related to your redemption of the program assistance may be collected, analyzed, and shared with Pfizer, for market research and other purposes related to assessing Pfizer's programs. Data shared with Pfizer will be aggregated and de-identified; it will be combined with data related to other assistance redemptions and will not identify you.
• Pfizer reserves the right to rescind, revoke or amend this program without notice.
• This program may not be available to patients in all states.
• For more information about Pfizer, visit www.pfizer.com. For more information about the Pfizer Oncology Together Co-Pay Savings Program for Injectables, visit pfizeroncologytogether.com, call 1-877-744-5675, or write to Pfizer Oncology Together Co-Pay Savings Program for Injectables, 2730 S. Edmonds Lane, Suite 300, Lewisville, TX 75067.
• Program terms and offer will expire at the end of each calendar year. Before the calendar year ends, you will receive information and eligibility requirements for continued participation.

INFLECTRA^® (infliximab-dyyb)
Terms and Conditions:
By using this Co-Pay Program, you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions below:

• The Pfizer enCompass^® Co-Pay Assistance Program for INFLECTRA is not valid for patients who are enrolled in a state- or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as "La Reforma de Salud").
• Program offer is not valid for cash-paying patients. With this program, eligible patients may pay as little as $0 co-pay per INFLECTRA treatment, subject to a maximum benefit of $3,000 to $12,000 per calendar year for out-of-pocket expenses for INFLECTRA, including co-pays or coinsurances. The amount of any benefit is the difference between your co-pay and $0. After the maximum of $3,000 to $12,000, you will be responsible for the remaining out-of-pocket costs.
• Patient must have private insurance with coverage of INFLECTRA. This offer is not valid when the entire cost of your prescription drug is eligible to be reimbursed by your private insurance plans or other private health or pharmacy benefit programs.
• You must deduct the value of this assistance from any reimbursement request submitted to your private insurance plan, either directly by you or on your behalf.
• You are responsible for reporting use of the program to any private insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the program, as may be required. You should not use the program if your insurer or health plan prohibits use of manufacturer co-pay assistance programs.
• This program is not valid where prohibited by law.
• The benefit under the program is offered to, and intended for the sole benefit of, eligible patients and may not be transferred to or utilized for the benefit of third parties, including, without limitation, third party payers, pharmacy benefit managers, or the agents of either.
• This program cannot be combined with any other external savings, free trial or similar offer for the specified prescription (including any program offered by a third-party payer or pharmacy benefit manager, or an agent of either, that adjusts patient cost-sharing obligations, through arrangements that may be referred to as "accumulator" or "maximizer" programs).
• Third party payers, pharmacy benefit managers, or the agents of either, are prohibited from assisting patients with enrolling in the program.
• Co-pay card will be accepted only at participating pharmacies.
• This program is not health insurance.
• This program is good only in the U.S. and Puerto Rico.
• This program is limited to 1 per person during this offering period and is not transferable.
• No other purchase is necessary.
• Data related to your redemption of the program assistance may be collected, analyzed, and shared with Pfizer, for market research and other purposes related to assessing Pfizer's programs. Data shared with Pfizer will be aggregated and de-identified; it will be combined with data related to other assistance redemptions and will not identify you.
• Pfizer reserves the right to rescind, revoke or amend this program without notice.
• This program may not be available to patients in all states.
• For more information about Pfizer, visit www.pfizer.com. For more information about the Pfizer enCompass Co-Pay Assistance Program, call Pfizer enCompass at 1-844-722-6672, or write to Pfizer enCompass Co-Pay Assistance Program at 2730 S. Edmonds Lane, Suite 300, Lewisville, TX 75067.
• Program terms and offer will expire at the end of each calendar year. Before the calendar year ends, you will receive information and eligibility requirements for continued participation.

NIVESTYM^® (filgrastim-aafi)
Terms and Conditions:
By using this Co-Pay Program for Injectables program, you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions described below:

• The Pfizer Oncology Together™ Co-Pay Savings Program for Injectables for NIVESTYM is not valid for patients who are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as "La Reforma de Salud").
• Program offer is not valid for cash-paying patients.
• With this program, eligible patients may pay as little as $0 co-pay per NIVESTYM treatment, subject to a maximum benefit of $4,000 to $10,000 per calendar year for out-of-pocket expenses for NIVESTYM including co-pays or coinsurances. The amount of any benefit is the difference between your co-pay and $0. After the maximum of $4,000 to $10,000 you will be responsible for the remaining monthly out-of-pocket costs.
• Patient must have private insurance with coverage of NIVESTYM. This offer is not valid when the entire cost of your prescription drug is eligible to be reimbursed by your private insurance plans or other private health or pharmacy benefit programs.
• You must deduct the value of this assistance from any reimbursement request submitted to your private insurance plan, either directly by you or on your behalf.
• You are responsible for reporting use of the program to any private insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the program, as may be required. You should not use the program if your insurer or health plan prohibits use of manufacturer co-pay assistance programs.
• Whether a co-pay expense is eligible for the Pfizer Oncology Together Injectables Co-Pay Program for NIVESTYM benefit will be determined at the time the benefit is paid. Co-pay expenses must be in connection with a separately paid claim for NIVESTYM administered in the outpatient setting.
• This program is not valid where prohibited by law. The benefit under the program is offered to, and intended for the sole benefit of, eligible patients and may not be transferred to or utilized for the benefit of third parties, including, without limitation, third party payers, pharmacy benefit managers, or the agents of either.
• This program cannot be combined with any other external savings, free trial or similar offer for the specified prescription (including any program offered by a third-party payer or pharmacy benefit manager, or an agent of either, that adjusts patient cost-sharing obligations, through arrangements that may be referred to as "accumulator" or "maximizer" programs).
• Third party payers, pharmacy benefit managers, or the agents of either, are prohibited from assisting patients with enrolling in the program.
• Co-pay card will be accepted only at participating pharmacies.
• This program is not health insurance.
• This program is good only in the U.S. and Puerto Rico.
• This program is limited to 1 per person during this offering period and is not transferable.
• No other purchase is necessary.
• Data related to your redemption of the program assistance may be collected, analyzed, and shared with Pfizer, for market research and other purposes related to assessing Pfizer's programs. Data shared with Pfizer will be aggregated and de-identified; it will be combined with data related to other assistance redemptions and will not identify you.
• Pfizer reserves the right to rescind, revoke or amend this program without notice.
• This program may not be available to patients in all states.
• For more information about Pfizer, visit www.pfizer.com. For more information about the Pfizer Oncology Together Co-Pay Savings Program for Injectables, visit pfizeroncologytogether.com, call 1-877-744-5675, or write to Pfizer Oncology Together Co-Pay Savings Program for Injectables, 2730 S. Edmonds Lane, Suite 300, Lewisville, TX 75067.
• Program terms and offer will expire at the end of each calendar year. Before the calendar year ends, you will receive information and eligibility requirements for continued participation.

NYVEPRIA^® (pegfilgrastim-apgf)
Terms and Conditions:
By using this Co-Pay Program, you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions described below:

• The Pfizer Oncology Together™ Co-Pay Savings Program for Injectables for NYVEPRIA is not valid for patients who are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as "La Reforma de Salud").
• Program offer is not valid for cash-paying patients. With this program, eligible patients may pay as little as $0 co-pay per NYVEPRIA treatment, subject to a maximum benefit of $4,000 to $10,000 per calendar year for out-of-pocket expenses for NYVEPRIA including co-pays or coinsurances. The amount of any benefit is the difference between your co-pay and $0. After the maximum of $4,000 to $10,000 you will be responsible for the remaining monthly out-of-pocket costs.
• Patient must have private insurance with coverage of NYVEPRIA. This offer is not valid when the entire cost of your prescription drug is eligible to be reimbursed by your private insurance plans or other private health or pharmacy benefit programs.
• You must deduct the value of this assistance from any reimbursement request submitted to your private insurance plan, either directly by you or on your behalf. You are responsible for reporting use of the program to any private insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the program, as may be required. You should not use the program if your insurer or health plan prohibits use of manufacturer co-pay assistance programs.
• Whether a co-pay expense is eligible for the Pfizer Oncology Together Injectables Co-Pay Program for NYVEPRIA benefit will be determined at the time the benefit is paid. Co-pay expenses must be in connection with a separately paid claim for NYVEPRIA administered in the outpatient setting.
• This program is not valid where prohibited by law.
• The benefit under the program is offered to, and intended for the sole benefit of, eligible patients and may not be transferred to or utilized for the benefit of third parties, including, without limitation, third party payers, pharmacy benefit managers, or the agents of either.
• This program cannot be combined with any other external savings, free trial or similar offer for the specified prescription (including any program offered by a third-party payer or pharmacy benefit manager, or an agent of either, that adjusts patient cost-sharing obligations, through arrangements that may be referred to as "accumulator" or "maximizer" programs).
• Third party payers, pharmacy benefit managers, or the agents of either, are prohibited from assisting patients with enrolling in the program.
• Co-pay card will be accepted only at participating pharmacies.
• This program is not health insurance.
• This program is good only in the U.S. and Puerto Rico.
• This program is limited to 1 per person during this offering period and is not transferable.
• No other purchase is necessary.
• Data related to your redemption of the program assistance may be collected, analyzed, and shared with Pfizer, for market research and other purposes related to assessing Pfizer's programs. Data shared with Pfizer will be aggregated and de-identified; it will be combined with data related to other assistance redemptions and will not identify you.
• Pfizer reserves the right to rescind, revoke or amend this program without notice.
• This program may not be available to patients in all states.
• For more information about Pfizer, visit www.pfizer.com. For more information about the Pfizer Oncology Together Co-Pay Savings Program for Injectables, visit pfizeroncologytogether.com, call 1-877-744-5675, or write to Pfizer Oncology Together Co-Pay Savings Program for Injectables, 2730 S. Edmonds Lane, Suite 300, Lewisville, TX 75067.
• Program terms and offer will expire at the end of each calendar year. Before the calendar year ends, you will receive information and eligibility requirements for continued participation.

RUXIENCE^® (rituximab-pvvr)
Terms and Conditions:
By using this Co-Pay Program, you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions below:

• The Pfizer Oncology Together™ Co-Pay Savings Program for Injectables for RUXIENCE and the Pfizer enCompass Co-Pay^® Assistance Program for RUXIENCE are not valid for patients who are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as "La Reforma de Salud").
• Program offer is not valid for cash-paying patients.
• Patients prescribed RUXIENCE for pemphigus vulgaris are not eligible for this co-pay savings program.
• With this program, eligible patients may pay as little as $0 co-pay per RUXIENCE treatment, subject to a maximum benefit of $25,000 per calendar year for out-of-pocket expenses for RUXIENCE, including co-pays or coinsurances. The amount of any benefit is the difference between your co-pay and $0. After the maximum benefit, you will be responsible for the remaining monthly out-of-pocket costs.
• Patient must have private insurance with coverage of RUXIENCE. This offer is not valid when the entire cost of your prescription drug is eligible to be reimbursed by your private insurance plans or other private health or pharmacy benefit programs.
• You must deduct the value of this assistance from any reimbursement request submitted to your private insurance plan, either directly by you or on your behalf.
• You are responsible for reporting use of the program to any private insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the program, as may be required. You should not use the program if your insurer or health plan prohibits use of manufacturer co-pay assistance programs.
• Whether a co-pay expense is eligible for the Pfizer Injectables Co-Pay Program for RUXIENCE benefit will be determined at the time the benefit is paid. Co-pay expenses must be in connection with a separately paid claim for RUXIENCE administered in the outpatient setting.
• Patient must be 18 years of age or older for redemption of co-pay card for RUXIENCE.
• This program is not valid where prohibited by law.
• The benefit under the program is offered to, and intended for the sole benefit of, eligible patients and may not be transferred to or utilized for the benefit of third parties, including, without limitation, third party payers, pharmacy benefit managers, or the agents of either.
• This program cannot be combined with any other external savings, free trial or similar offer for the specified prescription (including any program offered by a third-party payer or pharmacy benefit manager, or an agent of either, that adjusts patient cost-sharing obligations, through arrangements that may be referred to as "accumulator" or "maximizer" programs).
• Third party payers, pharmacy benefit managers, or the agents of either, are prohibited from assisting patients with enrolling in the program.
• Co-pay card will be accepted only at participating pharmacies.
• This program is not health insurance.
• This program is good only in the U.S. and Puerto Rico.
• This program is limited to 1 per person during this offering period and is not transferable. No other purchase is necessary.
• Data related to your redemption of the program assistance may be collected, analyzed, and shared with Pfizer, for market research and other purposes related to assessing Pfizer's programs. Data shared with Pfizer will be aggregated and de-identified; it will be combined with data related to other assistance redemptions and will not identify you.
• Pfizer reserves the right to rescind, revoke or amend this program without notice.
• This program may not be available to patients in all states.
• For more information about Pfizer, visit www.pfizer.com. For more information about the Pfizer Oncology Together Co-Pay Savings Program for Injectables for RUXIENCE, visit pfizeroncologytogether.com, call 1-877-744-5675. For more information about the Pfizer enCompass Co-Pay Assistance Program for RUXIENCE for non-oncology indications, call Pfizer enCompass at 1-844-722-6672. Or write to either of these programs at 2730 S. Edmonds Lane, Suite 300, Lewisville, TX 75067.
• Program terms and offer will expire at the end of each calendar year. Before the calendar year ends, you will receive information and eligibility requirements for continued participation.

TIVDAK^® (tisotumab vedotin-tftv)
Terms and Conditions:
By using the Pfizer Oncology Together™ Co-Pay Savings Program for Injectables for TIVDAK, you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions described below:

• Eligible patients with commercial prescription drug insurance coverage for TIVDAK may pay as little as $0 or per administration. Patient out of pocket expense will vary. The value of this offer is limited to annual benefit of $25,000. Once a patient reaches the annual maximum benefit patient is responsible for paying the remaining monthly out of pocket costs.
• Patients are not eligible for this offer if they are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veteran Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as "La Reforma de Salud").
• Patient must have private insurance. Offer is not valid for cash paying patients.
• This offer is not valid when the entire cost of your prescription drug is eligible to be reimbursed by your private insurance plan or other private health or pharmacy benefit programs.
• You must deduct the value of this offer from any reimbursement request submitted to your private insurance plan, either directly by you or on your behalf.
• You are responsible for reporting use of the Pfizer Oncology Together Co-Pay Savings Program for Injectables for TIVDAK to any private insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the co-pay card, as may be required. You should not use the co-pay card if your insurer or health plan prohibits use of manufacturer co-pay cards.
• You must be 18 years of age or older to redeem the co-pay card.
• The Pfizer Oncology Together Co-Pay Savings Program for Injectables for TIVDAK is not valid where prohibited by law.
• The benefit under the Pfizer Oncology Together Co-Pay Savings Program for Injectables for TIVDAK is offered to, and intended for the sole benefit of, eligible patients and may not be transferred to or utilized for the benefit of third parties, including, without limitation, third party payers, pharmacy benefit managers, or the agents of either.
• Third party payers, pharmacy benefit managers, or the agents of either, are prohibited from assisting patients with enrolling in the Pfizer Oncology Together Co-Pay Savings Program for Injectables for TIVDAK.
• The Pfizer Oncology Together Co-Pay Savings Program for Injectables for TIVDAK cannot be combined with any other external savings, free trial or similar offer for the specified prescription (including any program offered by a third party payer or pharmacy benefit manager, or an agent of either, that adjusts patient cost- sharing obligations, through arrangements that may be referred to as "accumulator adjustment" or "co-pay maximizer" programs)
• Some health insurers or pharmacy benefit managers (or their agents) may have established accumulator adjustment or co-pay maximizer programs based on the availability of support under the Pfizer Oncology Together Co-Pay Savings Program for Injectables for TIVDAK and/or exclude the financial assistance provided under the offer co-pay card program from counting towards patient deductibles or out-of-pocket cost limitations.
• Patients subject to an accumulator adjustment or co-pay maximizer program are not eligible for this offer. Since you may be unaware whether you are subject to an accumulator adjustment or co-pay maximizer program when you enroll in this offer, Pfizer may monitor program utilization data and reserves the right to discontinue, reduce, or otherwise modify this offer at any time without notice.
• Co-pay card will be accepted only at participating pharmacies.
• If your pharmacy does not participate, you may be able to submit a request for a rebate in connection with this offer.
• The Pfizer Oncology Together Co-Pay Savings Program for Injectables for TIVDAK is not health insurance.
• Offer good only in the U.S. and Puerto Rico.
• The Pfizer Oncology Together Co-Pay Savings Program for Injectables for TIVDAK is limited to 1 per person during this offering period and is not transferable.
• No other purchase is necessary.
• Data related to your redemption of the Pfizer Oncology Together Co-Pay Savings Program for Injectables for TIVDAK may be collected, analyzed, and shared with Pfizer, for market research and other purposes related to assessing Pfizer's programs. Data shared with Pfizer will be aggregated and de-identified; it will be combined with data related to other co-pay card redemptions and will not identify you.
• Pfizer reserves the right to rescind, revoke or amend this offer without notice.
• Offer expires 12/31/2025.
• For questions regarding the offer, please call 1-877-744-5675, visit https://www.pfizeroncologytogether.com/ or write Pfizer Oncology Together Co-Pay Savings Program for Injectables, 2730 S. Edmonds Lane, Suite 300, Lewisville, TX 75067.

TRAZIMERA^® (trastuzumab-qyyp)
Terms and Conditions:
By using this Co-Pay Program, you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions described below:

• The Pfizer Oncology Together™ Co-Pay Savings Program for Injectables for TRAZIMERA is not valid for patients who are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as "La Reforma de Salud").
• Program offer is not valid for cash-paying patients. With this program, eligible patients may pay as little as $0 co-pay per TRAZIMERA treatment, subject to a maximum benefit of $25,000 per calendar year for out-of-pocket expenses for TRAZIMERA including co-pays or coinsurances. The amount of any benefit is the difference between your co-pay and $0. After the maximum of $25,000 you will be responsible for the remaining monthly out-of-pocket costs.
• Patient must have private insurance with coverage of TRAZIMERA. This offer is not valid when the entire cost of your prescription drug is eligible to be reimbursed by your private insurance plans or other private health or pharmacy benefit programs.
• You must deduct the value of this assistance from any reimbursement request submitted to your private insurance plan, either directly by you or on your behalf.
• You are responsible for reporting use of the program to any private insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the program, as may be required. You should not use the program if your insurer or health plan prohibits use of manufacturer co-pay assistance programs.
• Whether a co-pay expense is eligible for the Pfizer Oncology Together Injectables Co-Pay Program for TRAZIMERA benefit will be determined at the time the benefit is paid. Co-pay expenses must be in connection with a separately paid claim for TRAZIMERA administered in the outpatient setting.
• Patient must be 18 years of age or older for redemption of co-pay card.
• This program is not valid where prohibited by law.
• The benefit under the program is offered to, and intended for the sole benefit of, eligible patients and may not be transferred to or utilized for the benefit of third parties, including, without limitation, third party payers, pharmacy benefit managers, or the agents of either.
• This program cannot be combined with any other external savings, free trial or similar offer for the specified prescription (including any program offered by a third-party payer or pharmacy benefit manager, or an agent of either, that adjusts patient cost-sharing obligations, through arrangements that may be referred to as "accumulator" or "maximizer" programs).
• Third party payers, pharmacy benefit managers, or the agents of either, are prohibited from assisting patients with enrolling in the program.
• Co-pay card will be accepted only at participating pharmacies.
• This program is not health insurance.
• This program is good only in the U.S. and Puerto Rico.
• This program is limited to 1 per person during this offering period and is not transferable.
• No other purchase is necessary.
• Data related to your redemption of the program assistance may be collected, analyzed, and shared with Pfizer, for market research and other purposes related to assessing Pfizer's programs. Data shared with Pfizer will be aggregated and de-identified; it will be combined with data related to other assistance redemptions and will not identify you.
• Pfizer reserves the right to rescind, revoke or amend this program without notice.
• This program may not be available to patients in all states.
• For more information about Pfizer, visit www.pfizer.com. For more information about the Pfizer Oncology Together Co-Pay Savings Program for Injectables, visit pfizeroncologytogether.com, call 1-877-744-5675, or write to Pfizer Oncology Together Co-Pay Savings Program for Injectables, 2730 S. Edmonds Lane, Suite 300, Lewisville, TX 75067.
• Program terms and offer will expire at the end of each calendar year. Before the calendar year ends, you will receive information and eligibility requirements for continued participation.

ZIRABEV^® (bevacizumab-bvzr)
Terms and Conditions:
By using this program, you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions described below:

• The Pfizer Oncology Together™ Co-Pay Savings Program for Injectables for ZIRABEV is not valid for patients who are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as "La Reforma de Salud").
• Program offer is not valid for cash-paying patients.
• Patients prescribed ZIRABEV for hepatocellular carcinoma are not eligible for this co-pay savings program.
• With this program, eligible patients may pay as little as $0 co-pay per ZIRABEV treatment, subject to a maximum benefit of $25,000 per calendar year for out-of-pocket expenses for ZIRABEV including co-pays or coinsurances. The amount of any benefit is the difference between your co-pay and $0. After the maximum of $25,000 you will be responsible for the remaining monthly out-of-pocket costs.
• Patient must have private insurance with coverage of ZIRABEV. This offer is not valid when the entire cost of your prescription drug is eligible to be reimbursed by your private insurance plans or other private health or pharmacy benefit programs.
• You must deduct the value of this assistance from any reimbursement request submitted to your private insurance plan, either directly by you or on your behalf.
• You are responsible for reporting use of the program to any private insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the program, as may be required. You should not use the program if your insurer or health plan prohibits use of manufacturer co-pay assistance programs.
• Whether a co-pay expense is eligible for the Pfizer Oncology Together Injectables Co-Pay Program for ZIRABEV benefit will be determined at the time the benefit is paid. Co-pay expenses must be in connection with a separately paid claim for ZIRABEV administered in the outpatient setting.
• Patient must be 18 years of age or older for redemption of co-pay card.
• This program is not valid where prohibited by law.
• The benefit under the program is offered to, and intended for the sole benefit of, eligible patients and may not be transferred to or utilized for the benefit of third parties, including, without limitation, third party payers, pharmacy benefit managers, or the agents of either.
• This program cannot be combined with any other external savings, free trial or similar offer for the specified prescription (including any program offered by a third-party payer or pharmacy benefit manager, or an agent of either, that adjusts patient cost-sharing obligations, through arrangements that may be referred to as "accumulator" or "maximizer" programs).
• Third party payers, pharmacy benefit managers, or the agents of either, are prohibited from assisting patients with enrolling in the program.
• Co-pay card will be accepted only at participating pharmacies.
• This program is not health insurance.
• This program is good only in the U.S. and Puerto Rico.
• This program is limited to 1 per person during this offering period and is not transferable.
• No other purchase is necessary.
• Data related to your redemption of the program assistance may be collected, analyzed, and shared with Pfizer, for market research and other purposes related to assessing Pfizer's programs. Data shared with Pfizer will be aggregated and de-identified; it will be combined with data related to other assistance redemptions and will not identify you.
• Pfizer reserves the right to rescind, revoke or amend this program without notice.
• This program may not be available to patients in all states.
• For more information about Pfizer, visit www.pfizer.com. For more information about the Pfizer Oncology Together Co-Pay Savings Program for Injectables, visit pfizeroncologytogether.com, call 1-877-744-5675, or write to Pfizer Oncology Together Co-Pay Savings Program for Injectables, 2730 S. Edmonds Lane, Suite 300, Lewisville, TX 75067.
• Program terms and offer will expire at the end of each calendar year. Before the calendar year ends, you will receive information and eligibility requirements for continued participation.